Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0578320080250030352
Molecules and Cells
2008 Volume.25 No. 3 p.352 ~ p.357
Structure-Function of the TNF Receptor-like Cysteine-rich Domain of Osteoprotegerin
Shin Joon

Kim Young-Mee
Li Song-Zhe
Lim Sung-Kil
Lee Weon-Tae
Abstract
Osteoprotegerin (OPG) is a soluble decoy receptor that inhibits osteoclastogenesis and is closely associated with bone resorption processes. We have designed and determined the solution structures of potent OPG analogue peptides, derived from sequences of the cysteine-rich domain of OPG. The inhibitory effects of the peptides on osteoclastogenesis are dose-dependent (10(-6)M-10(-4)M), and the activity of the linear peptide at 10(-4)M is ten-fold higher than that of the cyclic OPG peptide. Both linear and cyclic peptides have a ¥â-turn-like conformation and the cyclic peptide has a rigid conformation, suggesting that structural flexibility is an important factor for receptor binding. Based on structural and biochemical information about RANKL and the OPG peptides, we suggest that complex formation between the peptide and RANKL is mediated by both hydrophobic and hydrogen bonding interactions. These results provide structural insights that should aid in the design of peptidyl-mimetic inhibitors for treating metabolic bone diseases caused by abnormal osteoclast recruitment.
KEYWORD
Bone Disease, NMR, OPG Analogue Peptides, Osteoprotegerin
FullTexts / Linksout information
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI)